Glenmark Gets Tentative FDA Approval for Generic Breast Cancer Injection Drug, an Industrial Info Market Brief

Indian pharmaceutical manufacturer Glenmark Pharmaceuticals Limited on Friday said its U.S.-based subsidiary, Glenmark Pharmaceuticals Incorporated, has received tentative approval from the U.S. Food and Drug Administration (FDA) for the injectable drug Fulvestrant.
Login to Read More